A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
The prototype endothelial marker PAL-E is a leukocyte trafficking molecule.
Tekijät: Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S
Kustantaja: AMER SOC HEMATOLOGY
Kustannuspaikka: Washington DC
Julkaisuvuosi: 2009
Journal: Blood
Tietokannassa oleva lehden nimi: Blood
Lehden akronyymi: Blood
Vuosikerta: 114
Numero: 2
Aloitussivu: 478
Lopetussivu: 84
Sivujen määrä: 7
ISSN: 1528-0020
DOI: https://doi.org/10.1182/blood-2008-11-188763
Pathologische Anatomie Leiden-endothelium antibody has been used for more than 20 years as a marker for vascular endothelium. Despite its widespread use, the target of this antibody was only recently identified as plasmalemma vesicle-associated protein-1 (PV-1). However, no function has been identified for this molecule. Here we report that activation of human umbilical vein endothelial cells with tumor necrosis factor-alpha resulted in a remarkable redistribution of PV-1 toward the peripheral areas of the cells. Furthermore, in vitro endpoint transmigration experiments showed that transcellularly migrating lymphocytes are surrounded by rings containing PV-1 and caveolin-1. Moreover, PV-1 associates physically with vimentin. In addition, administration of anti-PV-1 antibody during capillary flow assays resulted in a significant inhibition of lymphocyte transmigration through the endothelial cell layer, whereas rolling and adhesion were unaffected. In vivo blockage of PV-1 by an antibody in acute peritonitis and air pouch model resulted in a significant decrease in the number of migrating leukocytes. Here we thus define leukocyte transendothelial migration as the first known function for PV-1.